Copyright
©The Author(s) 2023.
World J Cardiol. Aug 26, 2023; 15(8): 375-394
Published online Aug 26, 2023. doi: 10.4330/wjc.v15.i8.375
Published online Aug 26, 2023. doi: 10.4330/wjc.v15.i8.375
Table 4 Summary statements
| No. | PPIs are recommended |
| 1 | In single antiplatelet therapy in presence of risk factors (history of peptic disease; concomitant treatment with non-steroidal anti-inflammatory drugs or steroids; two of the following: Age > 65 yr, dyspeptic symptoms, and gastrointestinal reflux symptoms) |
| 2 | In double antiplatelet therapy |
| 3 | In dual and triple antithrombotic therapy |
| 4 | In single anticoagulant therapy in presence of risk factors (at least one of the following: Age > 75 yr; history of peptic disease; concomitant use of non-steroidal anti-inflammatory drugs) |
| Searching for Helicobacter pylori infection could be useful in patients starting aspirin therapy | |
- Citation: Abrignani MG, Lombardo A, Braschi A, Renda N, Abrignani V. Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of view. World J Cardiol 2023; 15(8): 375-394
- URL: https://www.wjgnet.com/1949-8462/full/v15/i8/375.htm
- DOI: https://dx.doi.org/10.4330/wjc.v15.i8.375